SCHEMBL4257936

SCHEMBL4257936

Cc1ccc(-c2nc3ccc(C)cn3c2CNC(=O)c2ccc(OCC(F)(F)F)nc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 6/20 0.47
CSNK1D P48730 1/20 0.46
CSNK1E P49674 1/20 0.46
GABRA1 P14867 2/20 0.46
GABRB2 P47870 2/20 0.46
KCNH2 Q12809 2/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
ALB P02768 1/20 0.46
CYP3A4 P08684 1/20 0.46
CHRM1 P11229 1/20 0.46
HPGD P15428 1/20 0.46
GABRB1 P18505 1/20 0.46
GABRG2 P18507 1/20 0.46
GABRB3 P28472 1/20 0.46
GABRA3 P34903 1/20 0.46
ADRA1A P35348 1/20 0.46
OPRK1 P41145 1/20 0.46
HTR2B P41595 1/20 0.46
GABRA2 P47869 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4255844 0.84 GABRA1 (0.53) EPHX2GABRA1GABRB2KCNH2KDM4E
SCHEMBL4262289 0.79 GABRA1 (0.56) GABRA1GABRB2KCNH2KDM4ELMNA
SCHEMBL4257110 0.78 TP53 (0.54) GABRA1GABRB2KCNH2KDM4ELMNA
SCHEMBL4258953 0.78 GABRA1 (0.52) GABRA1GABRB2KCNH2KDM4ELMNA
SCHEMBL4253167 0.77 GABRA1 (0.56) GABRA1GABRB2KCNH2KDM4ELMNA
SCHEMBL4253077 0.77 GABRA1 (0.58) GABRA1GABRB2KCNH2KDM4ELMNA
SCHEMBL4259245 0.75 GABRA1 (0.51) GABRA1GABRB2KCNH2KDM4ELMNA
SCHEMBL13970217 0.75 GABRA1 (0.53) GABRA1GABRB2KCNH2KDM4ELMNA
SCHEMBL8266201 0.75 GABRA1 (0.53) GABRA1GABRB2KCNH2KDM4ELMNA
SCHEMBL4262267 0.74 KDM4E (0.60) GABRA1GABRB2KCNH2KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814880-B1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO FERRER INT (ES) 2009-01-28 EP disclosed
EP-1814880-B1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO FERRER INT (ES) 2009-01-28 EP disclosed
US-20080200473-A1 Imidazo [1,2-a]Pyridine Compounds, Compositions, Uses and Methods Thereto FERRER INTERNACIONAL, S.A. (ES) 2008-08-21 US disclosed
US-20080200473-A1 Imidazo [1,2-a]Pyridine Compounds, Compositions, Uses and Methods Thereto FERRER INTERNACIONAL, S.A. (ES) 2008-08-21 US disclosed
EP-1814880-A1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO FERRER INTERNACIONAL, S.A. (ES) 2007-08-08 EP disclosed
WO-2006051063-A1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO FERRER INTERNACIONAL S. A. (ES) 2006-05-18 WO disclosed
WO-2006051063-A1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO FERRER INTERNACIONAL S. A. (ES) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200473-A1 Imidazo [1,2-a]Pyridine Compounds, Compositions, Uses and Methods Thereto GABRA1, GABRA2, GABRA3 EPHX2 1529/4885CSNK1D 802/4885CSNK1E 801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.